Rubin Lab


Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States.

Dolinger MT, Krugliak Cleveland N, Rubin DT, Dubinsky MC. Am J Gastroenterol. 2023. [Epub ahead of print March 20 2023]. PMID: 36940447.

Transient Suppression of Bacterial Populations Associated with Gut Helath is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn’s Disease​.

Runde J, Veseli I, Fogarty EC, Watson AR, Clayssen Q, Yosef M, Shaiber A, Verma R, Quince C, Gerasimidis K, Rubin DT, Murat Eren A. J Crohns Colitis. 2023. [Epub ahead of print March 19 2023]. PMID: 36934439.

Upadacitinib is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience.

Friedberg S, Choi D, Hunold T, Choi NK, Garcia NM, Picker EA, Cohen NA, Cohen RD, Dalal SR, Pekow J, Sakuraba A, Krugliak Cleveland N, Rubin DT. Clin Gastroenterol Hepatol. 2023. [Online ahead of print March 8 2023]. PMID: 36898598.

Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgerncy, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.

Danese S, Tran J, D’Haens G, Rubin DT, Aoyama N, Zhou W, Ilo D, Yao X, Sanchez Gonzalez Y, Panaccione R. Inflamm Bowel Dis. 2023. [Epub ahed of print Feb 15 2023]. PMID: 36790041.

Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.

Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Kotze PG, Gearry RB, Ng SC, Mak JWY, Abreu MT, Rubin DT, Bernstein CN, Banerjee R, Yamamoto-Furusho JK, Panaccione R, Seow CH, Ma C, Underwood FE, Ahuja V, Panaccione N, Shaheen AA, Holroyd-Leduc J, Kaplan GG, on behalf of the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group: Balderramo D, Chong VH, Juliao-Baños F, Dutta U, Simadibrata M, Kaibullayeva J, Sun Y, Hilmi I, Ali RAR, Paudel MS, Altuwaijri M, Hartono JL, Wei SC, Limsrivilai J, El Ouali S, Vergara BI, Dao VH, Kelly P, Hodges P, Miao Y, Li M. Clin Gastroenterol Hepatol. 2022. [Epub ahead of print Jul 19 2022]. PMID: 35863682.

Delays in Therapy Associated with Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.

Choi DK, Cohen NA, Choden T, Cohen RD, Rubin DT. Inflamm Bowel Dis. 2023. [Epub ahead of print Jan 30 2023]. 2023. PMID: 36715294.



Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is it Ready for Standard Practice?​.

Allocca M, Kucharzik T, Rubin DT. Gastroenterology. 2023. [Epub ahead of print Jan 25 2023]. PMID: 36708790.

Crohn’s disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomized controlled trial.

Zisman-Ilani Y, Thompson KD, Siegel LS, Mackenzie T, Crate DJ, Korzenik JR, Melmed GY, Kozuch P, Sands BE, Rubin DTRegueiro MD, Cross R, Wolf DC, Hanson JS, Schwartz RM, Vrabie R, Kreines MD, Scherer T, Dubinsky MC, Siegel CA. Aliment Pharmacol Ther. 2022. [Epub ahead of print Nov 14 2022]. PMID: 36377259.

Treat-to-target and sequencing therapies in Crohn’s disease.

Garcia NM, Cohen NA, Rubin DT. United European Gastroenterol J. Epub 2022. PMID: 36507876.

Diagnostic and Management Considerations for the Ileal Pouch Anal Anastomosis with Crohn’s Disease-Like Features.

Akiyama S,Dyer EC, Rubin DT. Dis Colon Rectum. 2022;65(S1):S77-S84. PMID: 35867686.